An Oral GLP-1 Receptor Agonist for Adults with Obesity | NEJM

preview_player
Показать описание
Easy-to-use, oral GLP-1 receptor agonists are of interest as alternatives to injectable formulations approved for weight reduction. An oral nonpeptide GLP-1 receptor agonist shows promise.

New research findings are summarized in this short video.

Рекомендации по теме
Комментарии
Автор

Well GET IT ON THE MARKET at an affordable price. Medicare & Medicaid both refuse to pay for weight loss meds. I lost 97 pounds on Ozempic but now had it yanked away.

sassylrhg
welcome to shbcf.ru